The store will not work correctly when cookies are disabled.
2-((4-chlorophenyl)amino)-5,8-dimethylimidazo[1',2':1,6]pyrido[2,3-d]pyrimidine-6-carbonitrile
ID: ALA4777250
PubChem CID: 162643221
Max Phase: Preclinical
Molecular Formula: C18H13ClN6
Molecular Weight: 348.80
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cn2c(n1)c(C#N)c(C)c1cnc(Nc3ccc(Cl)cc3)nc12
Standard InChI: InChI=1S/C18H13ClN6/c1-10-9-25-16(22-10)14(7-20)11(2)15-8-21-18(24-17(15)25)23-13-5-3-12(19)4-6-13/h3-6,8-9H,1-2H3,(H,21,23,24)
Standard InChI Key: BZIJUZKYOHEUHU-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
23.3740 -3.3625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.3728 -4.1899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0876 -4.6027 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.0858 -2.9498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8013 -3.3589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8020 -4.1858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2276 -3.3520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5117 -2.9447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2324 -4.1820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5157 -4.5934 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.6855 -5.4020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5071 -5.4906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8450 -4.7365 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.5073 -2.1197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9371 -2.9343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6491 -2.5175 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.6581 -4.6018 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.9179 -6.2061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9439 -4.1888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9491 -3.3639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2358 -2.9509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5200 -3.3629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5220 -4.1922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2359 -4.6014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8053 -2.9508 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 10 1 0
9 7 1 0
7 8 2 0
8 5 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 9 2 0
8 14 1 0
15 16 3 0
7 15 1 0
2 17 1 0
12 18 1 0
17 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
22 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 348.80 | Molecular Weight (Monoisotopic): 348.0890 | AlogP: 4.16 | #Rotatable Bonds: 2 |
Polar Surface Area: 78.90 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.65 | CX Basic pKa: 4.06 | CX LogP: 3.45 | CX LogD: 3.45 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.59 | Np Likeness Score: -1.63 |
References
1. Shi C,Wang Q,Liao X,Ge H,Huo G,Zhang L,Chen N,Zhai X,Hong Y,Wang L,Wang Z,Shi W,Mao Y,Yu J,Ke Y,Xia G. (2020) Discovery of a novel series of imidazo[1',2':1,6]pyrido[2,3-d]pyrimidin derivatives as potent cyclin-dependent kinase 4/6 inhibitors., 193 [PMID:32200202] [10.1016/j.ejmech.2020.112239] |